• No se han encontrado resultados

3. METODOLOGÍA

3.5 METODOLOGÍAS DE LAS PRUEBAS

3.5.1 Pruebas realizadas sobre las imágenes darks

3.5.1.1 Pruebas de bondad y ajuste a un vector construido con muestras

3.5.1.1.1 Manejo de atípicos

Alonso, C. A., Zaidi, T., Grundke-Iqbal, I. & Iqbal, K. (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer´s disease. Proc. Natl. Acad. Sci. USA 91, 5562- 5566.

Alzheimer, A. (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatrie Psychisch- Gerichtl. Med. 64, 146-148.

Arduengo, P.M., Appleberry, O.K., Chuang, P., L'Hernault, S.W. (1998) The presenilin protein family member SPE-4 localizes to an ER/Golgi derived organelle and is required for proper cytoplasmic partitioning during Caenorhabditis elegans spermatogenesis. J. Cell Sci. 111, 3645-3654.

Artavanis-Tsakonas, S., Matsuno, K., Fortini, M.E. (1995) Notch signaling. Science 268, 225-232. Artavanis-Tsakonas, S., Rand, M.D., Lake, R.J. (1999) Notch signaling: cell fate control and signal

integration in development. Science 284, 770-776.

Barelli, H., Lebeau, A., Vizzavona, J., Delaere, P., Chevallier, N., Drouot, C., Marambaud, P., Ancolio, K., Buxbaum, J.D., Khorkova, O., Heroux, J., Sahasrabudhe, S., Martinez, J., Warter, J.M., Mohr, M., Checler, F. (1997) Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 10, 695-707.

Baumeister, R., Leimer, U., Zweckbronner, I., Jakubek, C., Grünberg, J. & Haass, C. (1997) Human presenilin-1, but not familial Alzheimer’s disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct. 1, 149-159. Baumeister, R. & Haass, C. (1998) Presenilin proteins and their roles in development and Notch

signaling. In Molecular Biology of Alzheimer’s Disease (ed. Haass, C.) Harwood Academic Publishers, 219-234.

Bellosta, S., Nathan, B.P., Orth, M., Dong, L.-M., Mahley, R.W. & Pitas, R.E. (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270, 27063-27071.

Biernat, J., Mandelkow, E.-M., Schröter, C., Lichtenberg-Kraag, B., Steiner, B., Berkling, B., Meyer, H., Mercken, M., Vandermeeren, A., Goedert, M. & Mandelkow, E. (1992) The switch of tau protein to Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 11, 1593-1597.

Blacker, D., Wilcox, M.A., Lairs, N.M., Rodes, L., Horvath, S.M., Go, R.C.P., Perry, R., Watson, B., Bassett, S.S., McInnis, M.G., Albert, M.S., Hyman, B.T. & Tanzi, R.E. (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19, 357-360.

Bondareff, W., Harrington, C., Wischik, C.M., Hauser, D.L. & Roth, M. (1994) Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 53, 158-164

Literaturverzeichnis

--- Borchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport, F., Ratovitsky, T., Prada, C.M.,

Kim, G., Seekins, S., Yager, D., Slunt, H.H., Wang, R., Seeger, M., Levey, A.I., Gandy, S.E., Copeland, N.G., Jenkins, N.A., Price, D.L., Younkin, S.G., Sisodia, S.S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

Neuron 17, 1005-1013.

Braak, H. & Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.

Braak, H., Braak, E., Bohl J. & Reintjes R. (1996) Age, neurofibrillary changes, A-beta amyloid and the onset of Alzheimer´s disease. Neurosci. Lett. 210, 87-90.

Braak, H., Griffing, K. & Braak, E. (1997) Neuroanatomy of Alzheimer’s disease. Alzheimer’s Res. 3, 235-247.

Bracco, L., Piccini, C. & Amaducci, L. (1998) Rate of progression of mental decline in Alzheimer’s disease: Summary of european studies. Alzheimer Dis. Assoc. Disord. 12, 347-355.

Brandt, R. & Eidenmüller, J. (1998) The Tau proteins in Alzheimer’s disease (1998) In Molecular Biology of Alzheimer’s Disease (ed. Haass, C.) Harwood Academic Publishers, 17-43.

Brockhaus, M., Grunberg, J., Rohrig, S., Loetscher, H., Wittenburg, N., Baumeister, R., Jacobsen, H., Haass, C. (1998) Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport 9, 1481-1486.

Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J.R., Cumano, A., Roux, P., Black, R.A., Israel, A. (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5, 207-216.

Busciglio, J., Lorenzo, A. & Yankner, B.A. (1992) Methodological variables in the assessment of ß- amyloid neurotoxicity. Neurobiol. Aging 13, 609-612.

Busciglio, J., Lorenzo, A., Yeh, J. & Yankner, B.A.. (1995) ß-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.

Buxbaum, J.D., Liu, K.-N., Luo, Y., Slack, J.L., Stocking, K.L., Peschon, J.J., Johnson, R.S., Castner, B.J., Cerretti, D.P. & Black, R.A. (1998) Evidence that tumor necrosis factor α converting enzyme is involved in regulated γ-secretase cleavage of the Alzheimer amyloid protein precursor.

J. Biol. Chem. 273, 27765-27767.

Cai, X., Golde, T.E. & Younkin, S.G. (1993) Release of excess amyloid ß-protein from a mutant amyloid ß precursor. Science 259, 514-516.

Cao, X. & Südhof, T.C. (2001) A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60. Science 293, 115-120.

Capell, A., Saffrich, R., Olivo, J.-C., Meyn, L., Walter, J., Grünberg, J., Dotti, C. & Haass, C. (1997) Cellular expression and proteolytic processing of Presenilin is developmentally regulated during neuronal differentiation. J. Neurochem. 69, 2432-2440.

Capell, A., Grünberg, J., Pesold, B., Diehlmann, A., Citron, M., Nixon, R., Beyreuther, K., Selkoe, D.J. & Haass, C. (1998) The proteolytic fragments of the Alzheimer’s disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J. Biol. Chem. 273, 3205-3211.

Capell, A., Steiner, H., Romig, H., Keck, S., Baader, M., Grim, M.G., Baumeister, R., Haass, C. (2000) Presenilin-1 differentially facilitates endoproteolysis of the beta-amyloid precursor protein and Notch. Nat. Cell. Biol. 2, 205-211.

Castano, E.M., Prelli, F., Wisniewski, T., Golabek, A., Kumar, R.A., Soto, C. & Frangione, B. (1995) Fibrillogenesis in Alzheimer's disease of amyloid ß peptides and apolipoprotein E. Biochem. J. 306, 599-604.

Checler, F. (1995) Processing of the ß-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65, 1431-1444.

Chan, Y.M. & Jan, Y.N. (1999) Presenilins, processing of beta-amyloid precursor protein, and notch signaling. Neuron 23, 201-204.

Citron, M., Olersdorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. & Selkoe, D.J. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer´s disease increases beta-protein production. Nature 360, 672-674.

Citron, M., Teplow, D.B., Selkoe, D.J. (1995) Generation of amyloid beta protein from its precursor is sequence specific. Neuron 14, 661-670.

Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St George Hyslop, P., Selkoe, D.J. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72.

Citron, M., Eckman, C.B., Diehl, T.S., Corcoran, C., Ostaszewski. B.L., Xia, W., Levesque, G., St George Hyslop, P., Younkin, S.G., Selkoe, D.J. (1998) Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein. Neurobiol. Dis. 5, 107-116. Cook, D.G., Sung, J.C., Golde, T.E., Feldenstein, K.M., Wojczyk, B.S., Tanzi, R.E., Trojanowski, J.Q.,

Lee, V. M.-Y. & Doms, R.W. (1996) Expression and anlysis of presenilin 1 in a human neuronal system: Localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA, 93, 9223-9228. Cook, D.G., Forman, M.S., Sung, J.C., Leight, S., Kolson, D.L., Iwatsubo, T., Lee, V. M.-Y. & Doms,

R.W. (1997) Alzheimer’s Aß (1-42) is generated in the endoplasmic reticulum / intermediate compartment of NT2N cells. Nat. Med. 3, 1021-1023.

Coyle, J.T., Oster-Granite, M.L., Reeves, R.H. & Gearhart, J.D. (1988) Down syndrome, Alzheimer’s disease and the trisomy 16 mouse. Trends Neurosci. 11, 390-394.

Cribbs, D.H., Chen, L.S., Bende, S.M., LaFerla, F.M. (1996) Widespread neuronal expression of the presenilin-1 early-onset Alzheimer´s disease gene in the murine brain. Am. J. Pathol. 148, 1797- 1806.

Davis, J.A., Naruse, S., Chen, H., Eckman, C., Younkin, S., Price, D.L., Borchelt, D.R., Sisodia, S.S., Wong, P.C. (1998) An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 20, 603-609.

De Sauvage, F., & Octave, J.N. (1989) A novel mRNA of the A4 amyloid precursor gene coding for a possible secreted protein. Science 245, 651-653.

De Strooper, B., Umans L., Van Leuven F., Van Den Berghe H. (1993) Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway. J. Cell Biol. 295-304.

Literaturverzeichnis

--- De Strooper, B., Beullens, M., Contreras, B., Levesque, L., Craessaerts, K., Cordell, B., Moechars, D.,

Bollen, M., Fraser, P., St. George-Hyslop, P.E. & van Leuven, F. (1997) Phosphorylation, subcellular localization and membrane orientation of the Alzheimer’s disease-associated presenilins. J. Biol. Chem. 272, 3590-3598.

De Strooper, B. & Van Leuven, F. (1998) The cell biology of amyloid precursor protein. In Molecular Biology of Alzheimer’s Disease (ed. Haass, C.) Harwood Academic Publishers, 133-151.

De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K. & Van Leuven, F. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390.

De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craesserts, K., Mumm, J.S., Schroeter, E.H., Schrijvers, V., Wolfe, M.S., Ray, W.J., Goate, A. & Kopan, R. (1999) A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518-522. Delaere, P., Duyckaerts, C., He, Y., Piette, F. & Hauw, J.J. (1991) Subtypes and differential laminar

distributions of beta A4 deposits in Alzheimer´s disease: relationship with the intellectual status of 26 cases. Acta Neuropathol. 81, 328-335.

Dewji, N.N. & Singer, S.J. (1997) The seven-transmembrane spanning topography of the Alzheimer´s disease-related presenilin proteins in the plasma membranes of cultured cells. Proc. Natl. Acad. Sci. USA 94, 14025-14030.

Dickson, D.W. (1997) The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56, 321-339. Doan, A., Thinakaran, G., Borchelt, D.R., Slunt, H.H., Ratovitsky, T., Podlisny, M., Selkoe, D.J.,

Seeger, M., Gandy, S.E., Price, D.L. & Sisodia, S.S. (1996) Protein topology of presenilin 1.

Neuron 17, 1023-1030.

Donoviel, D.B., Hadjantonakis, A.K., Ikeda, M., Zheng, H., Hyslop, P.S., Bernstein, A. (1999) Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 2801- 2810.

Dovey, H.F., Suomensaari-Chrysler, S., Lieberburg, I., Sinha, S & Keim, P.S. (1993) Cells with a familial Alzheimer´s disease mutation produce authentic ß-peptide. Neurochemistry 4, 1039- 1042.

Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M.N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., Younkin, S. (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature

383, 710-713.

Eidelberg, D., Sotrel, A., Joachim, C., Selkoe, D.J., Forman, A., Pendlebury, W.W., Perl, D.P. (1987) Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. Brain 110, 993-1013.

Ernst, R.L. & Hay, J.W. (1997) Economic research on Alzheimer disease: A review of the literature.

Alzheimer Dis. Assoc. Disord. 11, 135-145.

Esch, F.S., Keim, P.S., Beattie, E.C., Blacher, R.W., Culwell, A.R., Oltersdorf, T., McClure, D. & Ward, P.J. (1990) Cleavage of amyloid ß-peptide during constitutive processing of its precursor. Science

Esler, W.P., Kimberly, W.T., Ostaszewski, B.L., Diehl, T.S., Moore, C.L., Tsai, J.Y., Rahmati, T., Xia, W., Selkoe, D.J., Wolfe, M.S. (2000) Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat. Cell Biol. 2, 428-434.

Evans, K.C., Berger, E.P., Cho, C.-G., Weisgerber, K.H. & Lansbury, P.T. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad, Sci. USA 92, 763.767.

Fagan, A.M., Bu, G., Sun, Y., Daugherty, A. & Holtzman, D.M. (1996) Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271, 30121-30125.

Ferris, S.H. & Kluger, A. (1997) Assessing cognition in Alzheimer disease research. Alzheimer Dis. Assoc. Disord. 6, 45-49.

Fossgren, A., Brückner, B., Czech, C., Masters, C.L., Beyreuther, K. & Paro, R. (1998) Transgenic Drosophila expressing human amyloid precursor protein show γ-secretase activity and a blistered- wing phenotype. Proc. Natl. Acad. Sci. USA 95, 13703-13708.

Fraser, P.E. & St George-Hyslop, P.H. (1998) Mutations in three genes are associated with early onset alzheimer’s disease. In Molecular Biology of Alzheimer’s Disease (ed. Haass, C.) Harwood Academic Publishers, 47-73.

Friedhoff, P., von Bergen, M., Mandelkow, E.M., Mandelkow, E. (2000) Structure of tau protein and assembly into paired helical filaments. Biochim. Biophys. Acta 1502(1), 122-132.

Garver, T.D., Lehmann, R.A. & Billingsley, M.L. (1996) Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau and Alzheimer tau. J. Neurosci. Res. 44, 12- 20.

Geldmacher, D.S. & Whitehouse, P.J.Jr. (1997) Differential diagnosis of Alzheimer’s disease.

Neurology 48, S2-9.

Glenner, G.G. & Wong, C.W. (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.

Goedert, M. (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 16, 460-465.

Golde, T.E., Estus, S., Usiak, M., Younkin, L.H. & Younkin, S.G. (1990) Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternativel spliced form and quantitation in Alzheimer's disease using PCR. Neuron 4, 253-267.

Gong, C.-X., Shaikh, S., Wang, J.-Z., Zaidi, T., Grundke-Iqbal, I. & Iqbal, K. (1995) Phosphatase activity toward abnormally phosphorylated tau: Decrease in Alzheimer disease brain. J. Neurochem. 65, 732-738

Greenwald, I. (1998) LIN-12/Notch signaling: lessons from worms and flies. Genes Dev. 12, 1751-1762. Gridley, T. (1996) Notch, stroke and dementia. Nature 383, 673.

Grundke, I.I., Igbal., K., Tung, Y.C., Quinlan, M., Wisniewski, H.M., & Binder, L.I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology.

Literaturverzeichnis

--- Gu, Y., Oyama, F. & Ihara, Y. (1996). Tau is widely expressed in rat tissues. J. Neurochem. 67, 1235-

1244.

Haass, C., Hung, A.Y. & Selkoe, D.J. (1991) Processing of ß-amyloid precursor protein in microglia and astrocytes favors an internal localization over constiutive secretion. J. Neurosci. 11, 3783-3793. Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L.,

Lieberburg, I., Koo, E.H., Schenk, D., Teplow, D.B. & Selkoe, D.J. (1992a). Amyloid ß-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.

Haass, C., Koo, E., Mellon, A., Hung, A.Y. & Selkoe, D.J. (1992b) Targeting of cell-surface ß-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature

357, 500-503.

Haass, C. & Selkoe, D.J. (1993) Cellular processing of ß-amyloid precursor protein and the genesis of amyloid ß-peptide. Cell 75, 1039-1042.

Haass, C., Hung, A.Y., Schlossmacher, M.G., Teplow, D.B. & Selkoe, D.J. (1993) ß amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021- 3024.

Haass, C., Lemere, C.A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L. & Selkoe, D.J. (1995a) The Swedish mutation causes early-onset Alzheimer´s disease by ß-secretase cleavage within the secretory pathway. Nature Med. 1, 1291-1296.

Haass, C., Capell, A., Citron, M., Teplow, D.B. & Selkoe, D.J. (1995b) The vacuolar H+-ATPase

Inhibitor Bafilomycin A1 differently affects proteolytic processing of mutant and wild-type ß- amyloid precursor protein. J. Biol. Chem. 270, 6186-6192.

Haass, C., Koo, E.H., Capell, A., Teplow, D.B., Selkoe, D.J. (1995c) Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J. Cell Biol. 128, 537-547.

Haass, C. (1997) Presenilins: Genes for life and death. Neuron 18, 687-690.

Haass, C. & De Strooper, B. (1999). The presenilins in Alzheimer's disease - proteolysis holds the key.

Science 286, 916-919.

Hardy, J. (1997) Amyloid, the presenilins and Alzheimer’s disease. Trends Neurosci. 20, 154-159. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Jr. (1997a) Observation of metastable Aß amyloid

protofibrils by atomic force microscopy. Chem. Biol. 4, 119-125.

Harper J.D., Lieber C.M., Lansbury P.T. Jr. (1997b) Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer’s disease amyloid-ß protein. Chem. Biol. 4, 951- 959.

Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Jr. (1999) Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry. 38, 8972-8980. Hartmann, T., Bieger, S.C., Brühl, B., Tienari, P.J., Ida, N., Allsop, D., Roberts, G.W., Masters, C.L.,

Dotti, C.G., Unsicke, K. & Beyreuther, K. (1997) Distinct sites of intracellular production for Alzheimer’s disease Aß40/42 amyloid peptides. Nat. Med. 3, 1016-1020.

Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., Selkoe D.J. (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876-8884.

Hendriks, L. van Duijn, C.M., Cras, P., Cruts, M., van Hul, W., van Harskamp, F., Warren, A., McInnis, M.G., Antonarakis, S.E., Martin, J.J., Hofman, A. & van Brockhoeven, C. (1992) Presenile dementia and cerebral haemorraghe linked to a mutation at codon 692 of the ß-amyloid precursor protein gene. Nat. Genet. 1, 218-221.

Hennerici, M. (1995) Vascular dementia: a changing concept. Arzneimittelforschung 45, 366-370 Herreman, A., Hartmannn, D. Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L.,

Schrijvers, V., Vanderstichele, H., Baekelandt, V., Dressel, R., Cupers, P., Huylebroeck, D., Zwijsen, A., Van Leuven, F., De Strooper, B. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. USA 96, 11872- 11877.

Higuchi, R., Krummel, B., Saiki, R.K. (1988) A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16, 7351-7367.

Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., Pease, L.R. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction.Gene 77, 51-59.

Hoek, R.M., Ruuls, S.R., Murphy, C.A., Wright, G.J., Goddard, R., Zurawski, S.M., Blom, B., Homola, M.E., Streit, W.J., Brown, M.H., Barclay, A.N., Sedgwick, J.D. (2001) Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290, 1768-1771.

Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B.I., Geschwind, D.H., Bird, T.D., McKeel, D., Goate, A., Morris, J.C., Wilhelmsen, K.C., Schellenberg, G.D.,

Documento similar